Most people receive Keytruda infusions for up to 2 years. But in some cases, treatment may last longer if there’s evidence that the drug is still effective and the side effects are minimal.

They may pause or stop your Keytruda doses if your cancer gets worse (progresses) or if you have certain side effects. How Was Keytruda Studied for RCC? Keytruda was studied in people with ...

The FDA approved Padcev and Keytruda for advanced bladder cancer in December 2023, following accelerated approval for cisplatin-ineligible patients. Both treatments have lower odds of high-grade side ...